Arthrosis and curcumin

Osteoarthritis is a common cause of disability in the elderly. Today, available treatments include non-steroidal anti-inflammatory drugs – NSAIDs (ibuprofen), cyclooxygenase-2 inhibitors and surgery. NSAIDs, on the other hand, increase the risk of gastrointestinal adverse events (e. g. bleeding, ulcers and perforation of the stomach or intestines).

Previous studies have shown the effectiveness of curcumin in relieving the symptoms of joint arthritis. However, these studies show contradictory results because curcumin has a low oral bioavailability (Daily 2016). Indeed, the main limiting factor is the rapid glucuronidation/sulfatation of curcumin leading to low curcumin activity.

A new clinical study shows the effectiveness of Longvida® curcumin in reducing the symptoms of osteoarthritis of the knee

In order to solve the problem of low curcumin absorption in the body, scientists at the University of Los Angeles (UCLA) have developed Longvida® curcumin. Longvida® microencapsulation technology consists of encapsulating curcumin with stearic acid and sunflower lecithin. This innovative formula, therefore, increases the bioavailability of curcumin in its active form (free curcumin).

The objective of the study was to demonstrate the efficacy of Longvida® curcumin in reducing pain in patients with osteoarthritis of the knee (Gupte 2019).

Forty-two patients with osteoarthritis of the knee were randomized to receive either 400 mg twice daily of Curcumin Longvida® or 400 mg once daily of Ibuprofen for 90 days.

The main outcome evaluation criterion was pain reduction. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was used on days 0, 30, 60 and 90. The visual analogue scale (VAS) that measures pain perception was also recorded. During the study, inflammatory markers such as PGE2, TNF α, IL6, IL1β, LTB4, and the CTX II degenerative marker were analyzed.

2x400mg/day of Longvida® is equivalent to 400mg/day of ibuprofen to reduce knee pain and stiffness

The VAS and WOMAC scores decreased after 15 and 30 days, respectively. No differences between the two patient groups (curcumin Longvida® or ibuprofen) were observed. Thus, this result shows comparable efficacy in pain relief. In addition, none of the markers showed significant changes in either group (curcumin or ibuprofen).

This study shows that Longvida® curcumin has been shown to be effective and safe in relieving symptoms in patients with osteoarthritis of the knee when administered for 90 days.

Finally, the daily intake of 2x400mg/day of Longvida® is equivalent to 400mg/day of ibuprofen to reduce knee pain and stiffness.

Learn more about the Longvida formula

References:

Daily JW, Yang M, Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food. 2016 Aug;19(8):717-29. 

Gupte PA, Giramkar SA, Harke SM, Kulkarni SK, Deshmukh AP, Hingorani LL, Mahajan MP, Bhalerao SS, Evaluation of the efficacy and safety of Capsule Longvida® Optimized Curcumin (solid lipid curcumin particles) in knee osteoarthritis: a pilot clinical study. Journal of Inflammation Research. 2019(12):145-152.